Related Experiment Video
Updated: Nov 29, 2025
10:28
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
10.1K
Neuralgic amyotrophy and hepatitis E infection: 6 prospective case reports
Romain Garofoli1, Jennifer Zauderer2, Paul Seror3
1Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis, Hôpital Cochin, AP-HP.Centre-Université de Paris, Paris, France romaingarofoli@gmail.com.
RMD Open
|November 21, 2020
Summary
Hepatitis E virus (HEV) can cause neuralgic amyotrophy (NA). Early HEV screening is recommended for suspected NA, as it often presents severely but recovers within typical timelines.
Area of Science:
- Neurology
- Infectious Diseases
- Hepatology
Background:
- Hepatitis E virus (HEV) is a major cause of viral hepatitis globally.
- Neuralgic amyotrophy (NA) is a recognized neurological complication of HEV infection.
- Comprehensive data on the clinical, electrodiagnostic, and MRI features, along with long-term outcomes of HEV-related NA, are limited.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
1.7K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.7K
01:20Myasthenia Gravis: Overview and Treatment
2.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.5K